Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study

Bruno Brochet; Dawn Langdon; Eva Havrdová; Jeanette Lechner-Scott; Xavier Montalban; Francesco Patti; Fredrik Piehl; Alessandra Solari; Raymond Hupperts; Nektaria Alexandri; Annette Lehn; Andrzej Smyk; Krzysztof Selmaj; CLARIFY-MS Investigators

doi:10.1007/s40120-026-00897-0

March 10, 2026Neurology and TherapyOpen Access

Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study

View Full Paper

Ask AI

Bookmark

Share

Key Points

The study aims to evaluate the effects of cladribine tablets on cognitive function and employment stability in individuals with relapsing multiple sclerosis.
Conducted a phase IV clinical trial over two years.
Assessed cognitive function and employment status of participants.
Utilized specific clinical measures to evaluate outcomes.
Participants exhibited stable cognitive functioning over the study duration.
Employment rates among participants remained stable throughout the trial.
Cladribine treatment was associated with positive outcomes in cognition and employment.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Phase IV trial shows stability in cognition and employment in individuals with relapsing multiple sclerosis, indicating cladribine's potential benefits.

Abstract

URL: https://clinicaltrials.gov/ct2/show/NCT03369665 ; ClinicalTrials.gov Identifier: NCT03369665.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Brochet et al. (2026) studied this question.

synapsesocial.com/papers/69b3ab2902a1e69014ccbca2 https://doi.org/10.1007/s40120-026-00897-0

View Full Paper

Ask AI

Bookmark

Share

Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Stability in Cognition and Employment in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Two-year Phase IV CLARIFY-MS Study

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading